FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Cambridge, United Kingdom

Biotech startups in Cambridge, United Kingdom

Updated 16 Nov 2026

Reset
Biotech startups in Cambridge, United Kingdom
One-time CSV
  • 85 funded companies, 56 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~cambridge-cambridgeshire.csv85 rows × 18 columns
CompanyCityLast roundAmountDate
bit.bioCambridgeSeries D$25.0M2026-11-04
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
MicrobioticaCambridgeSeries C$47.9M2026-10-16
SparxellCambridgeSeed$5.0M2026-02-03
CellCentricCambridgeSeries D$220.0M2026-05-06
NucleraCambridgeSeries C$12.0M2026-01-13
Lucida MedicalCambridgeSeries A$11.5M2026-03-30
CytedCambridgeSeries B$44.0M2025-08-30

8 rows of the CSV in 5 of its 18 columns.

85
Startups
$3.0B
Total raised
16
Funded in the last 12 months
$748.2M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

13 of 85
13 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Series D $25.0M 2026-11-04 $250.0M Metaplanet, Foresite Capital 101 to 250 2016
Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
Lucida Medical Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. Biotech Series A $11.5M 2026-03-30 $22.5M Innovate UK, XTX Ventures, WDH Investments 11 to 50 2019
Sparxell Sparxell creates new colors and effects. Biotech Seed $5.0M 2026-02-03 $10.2M Katapult, Joyance Partners, Earth Venture Capital +1 11 to 50 2022
Nuclera Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. Biotech Series C $12.0M 2026-01-13 $157.8M Innovate UK, Verve Ventures, Amadeus Capital Partners +2 101 to 250 2013
Cyted Cyted uses AI and digital pathology to improve the detection and diagnosis of diseases, including cancer. Artificial intelligence Series B $44.0M 2025-08-30 $83.4M Innovate UK, MedTech Innovator, Morningside +1 51 to 100 2018
Shift Bioscience Shift Bioscience discovers drug targets for age-linked diseases using simulation. Artificial intelligence Seed $16.3M 2024-10-15 Healthspan Capital 11 to 50 2017
CardiaTec Biosciences CardiaTec Biosciences combines AI and expert talent to redesign cardiovascular drug discovery. Artificial intelligence Seed $6.5M 2024-09-10 APEX Ventures, Montage Ventures, Continuum Health Ventures +1 11 to 50 2021
Zetta Genomics Zetta Genomics manages large-scale genomic data for precision medicine. Biotech Seed $2.3M 2024-02-08 $8.0M Nina Capital, APEX Ventures, University of Cambridge Enterprise +1 11 to 50 2018
Apollo Therapeutics Apollo Therapeutics develops medicines by translating medical research into biopharmaceutical portfolios. Biotech Series C $33.5M 2024-01-02 $397.9M UCL Technology Fund, Patient Square Capital, Rock Springs Capital 51 to 100 2016
Mogrify Mogrify develops in vivo reprogramming therapies for patients with degenerative diseases. Biotech Series A $10.0M 2023-10-02 Parkwalk Advisors, 24 Haymarket, Ahren Innovation Capital 11 to 50 2019

Table 1. Biotech startups in Cambridge, United Kingdom: the 13 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 85.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
2 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
3 Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
4 bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Series D $25.0M 2026-11-04 $250.0M Metaplanet, Foresite Capital 101 to 250 2016
5 Nuclera Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. Biotech Series C $12.0M 2026-01-13 $157.8M Innovate UK, Verve Ventures, Amadeus Capital Partners +2 101 to 250 2013
6 Lucida Medical Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. Biotech Series A $11.5M 2026-03-30 $22.5M Innovate UK, XTX Ventures, WDH Investments 11 to 50 2019
7 Sparxell Sparxell creates new colors and effects. Biotech Seed $5.0M 2026-02-03 $10.2M Katapult, Joyance Partners, Earth Venture Capital +1 11 to 50 2022

Table 2. Biotech startups in Cambridge, United Kingdom: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Innovate UK Entrepreneurship program Swindon, United Kingdom 7 8% 3 CellCentric, Lucida Medical, Nuclera
2 University of Cambridge Enterprise University program Cambridge, United Kingdom 2 2% 1 T-Therapeutics
3 Cambridge Innovation Capital Venture capital firm Cambridge, United Kingdom 2 2% 2 T-Therapeutics, Microbiotica
4 Future Planet Capital Venture capital firm London, United Kingdom 2 2% 2 CellCentric, Nuclera
5 O2h Ventures Venture capital firm Hauxton, United Kingdom 2 2%
6 APEX Ventures Venture capital firm Vienna, Austria 2 2%
7 Foresite Capital Private equity firm San Francisco, United States 1 1% 1 bit.bio
8 Metaplanet Venture capital firm Tallinn, Estonia 1 1% 1 bit.bio
9 Sofinnova Partners Venture capital firm Paris, France 1 1% 1 T-Therapeutics
10 Digitalis Ventures Venture capital firm New York, United States 1 1% 1 T-Therapeutics
11 F-Prime Venture capital firm Cambridge, United States 1 1% 1 T-Therapeutics
12 British Patient Capital Venture capital firm Sheffield, United Kingdom 1 1% 1 Microbiotica
13 Seventure Partners Venture capital firm Paris, France 1 1% 1 Microbiotica
14 IP Group Venture capital firm London, United Kingdom 1 1% 1 Microbiotica
15 Joyance Partners Venture capital firm San Francisco, United States 1 1% 1 Sparxell

Table 3. Biotech startups in Cambridge, United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 66 78% $2.8B
Software 13 15% $140.5M
Artificial intelligence 9 11% $118.0M
Hardware 3 4% $14.7M
Energy 1 1% $2.8M
Education 1 1%

Table 4. Biotech startups in Cambridge, United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 9 11% $1.6M
Seed 29 34% $5.3M
Series A 19 22% $11.0M
Series B 15 18% $23.9M
Series C 8 9% $31.0M
Series D+ 5 6% $88.0M

Table 5. Biotech startups in Cambridge, United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 12% $158.0M
October 2026 2 12% $50.7M
September 2026 2 12% $1.1M
July 2026 1 6% $14.7M
May 2026 2 12% $221.6M
April 2026 1 6% $56.0M
March 2026 2 12% $98.6M
February 2026 2 12% $20.5M
January 2026 1 6% $12.0M
November 2025 1 6% $115.0M

Table 6. Biotech startups in Cambridge, United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 15 18% $633.2M
2025 9 11% $276.8M
2024 13 15% $134.2M
2023 8 9% $55.5M
2022 5 6% $11.8M
2021 6 7% $206.1M

Table 7. Biotech startups in Cambridge, United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 7 8%
2020 to 2022 15 18%
2015 to 2019 38 45%
2010 to 2014 17 20%
Before 2010 8 9%

Table 8. Biotech startups in Cambridge, United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 32 38%
11 to 50 41 49%
51 to 100 9 11%
101 to 250 2 2%

Table 9. Biotech startups in Cambridge, United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Cambridge, United Kingdom are on the list?
85, in the file dated 16 November 2026. 16 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 85 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Cambridge, United Kingdom: 85 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Cambridge, United Kingdom by funding stage

Other sectors in Cambridge

Biotech startups elsewhere

Cite: FundingWatcher, 85 funded biotech companies in Cambridge, United Kingdom, 16 November 2026. https://fundingwatcher.com/startups/biotech/cambridge-cambridgeshire/